Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Abdelgafur A"'
Autor:
Ilya Tsimafeyeu, Fedor Moiseenko, Sergei Orlov, Elena Filippova, Alexander Belonogov, Aleksey Nebesnykh, Amir Khalimov, Elena Karabina, Valentina Shikina, Ahmed Abdelgafur, Galina Statsenko, Irina Titova, Dmitry Isaichikov, Galina Makarnyaeva, Aleksey Mordovskiy, Oksana Barkovskaya, Aleksey Smirnov, Marina Gikalo, Nikita Savelov, Dmitry Kosov, Evgeny Imyanitov, Irina Demidova, Sergei Tjulandin
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-7 (2019)
PURPOSE: The overall survival (OS) results in patients with ALK-positive metastatic non–small-cell lung cancer (NSCLC) have rarely been reported. The aim of this prospective-retrospective cohort study was to obtain real-world data on the use of cri
Externí odkaz:
https://doaj.org/article/2ab879efa3684da48f55386215f32008
Autor:
V. V. Breder, I. A. Pokataev, Omar Ahmed Yousri Mohamed Zak Abdelgafur, I. V. Avramenko, A. Yu. Goryainova, N. M. Kiselyov
Publikováno v:
Medical alphabet. :7-12
Hepatocellular carcinoma (HCC) is a public health problem worldwide and is one of the most common and lethal cancers worldwide, the sixth among the most common cancers and the second mortal cancer worldwide. Viral hepatitis is the main risk factor. G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63c77cbbdbd543ab9954e7ad3b5a37e1
https://doi.org/10.33667/2078-5631-2022-26-7-12
https://doi.org/10.33667/2078-5631-2022-26-7-12
Autor:
Lylee Norah M. AbdelGafur
Publikováno v:
International Journal of Linguistics, Literature and Translation. 3:23-30
Pronunciation is a key element of the learning of oral skills in a second language. The role it plays in an English language program varies and the amount of time and effort devoted to it seems to depend to a large degree on the linguistic models and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63cf45635002bef70ed6151499fcfa68
https://doi.org/10.32996/ijllt.2021.4.8.4
https://doi.org/10.32996/ijllt.2021.4.8.4
Publikováno v:
Journal of Bioscience and Applied Research. :45-58
The low effectiveness of the existing ways of treatment of glomerulonephritis (GN) requires the development of new treatment methods and profound studying of mechanisms of development of (GN). A review of modern literature data indicates a relationsh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32206b828d30c426e6d1c72cbbb9e140
https://doi.org/10.21608/jbaar.2021.175196
https://doi.org/10.21608/jbaar.2021.175196
Autor:
M. I. Volkova, A. S. Kalpinskiy, P. S. Borisov, O. I. Evsyukova, A. S. Olshanskaya, V. B. Matveev, B. Ya. Alekseev, E. V. Peganova, A. F. Nasretdinov, E. V. Lymar, E. G. Ovchinnikova, T. A. Sveklina, E. A. Usynin, A. M. Abdelgafur, E. A. Tararova, L. M. Shumova, A. S. Belenkov, I. Yu. Dolgov, N. G. Ponomareva, I. V. Evstigneeva, A. N. Ivanov, A. R. Isaev, R. V. Leonenkov, A. V. Meskikh, M. R. Mukhitova, S. A. Orlova, I. V. Teslenok, M. M. Shegurova, M. T. Aivazov, Z. V. Amoev, K. G. Babina, A. A. Vorontsova, E. V. Karabina, N. V. Kirdakova, I. E. Shumskaya, G. P. Kolesnikov, E. S. Kuzmina, D. Kh. Latipova, E. S. Lyutova, M. M. Fael, A. N Chugarova, A. S. Antipin
Publikováno v:
Onkourologiâ, Vol 17, Iss 1, Pp 31-44 (2021)
Objective. The primary endpoint was progression-free survival; secondary endpoints included overall survival, objective response rate and duration, tumor control rate and duration, as well as safety profile of lenvatinib with everolimus in consecutiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b91177b36520353fff8907e4b001ccdd
https://doi.org/10.17650/1726-9776-2021-17-1-31-44
https://doi.org/10.17650/1726-9776-2021-17-1-31-44
Autor:
Peck Radosavljevic, M., Abdelgafur, A.M., Granito, A., Gasbarrini, A., Ma, Y., Mena, E., Lledó-Navarro, J.L., Presa, J., Weinmann, A., Levy, M.T., Pellicelli, A., Waldschmidt, D.T., Sørensen, H.T., Goyal, L., Ren, M., Saal, H., Okpara, C.E., Meyer, T.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S664-S664
Autor:
Dmitry Kosov, Marina Gikalo, Sergei Tjulandin, Sergei V. Orlov, Fedor Moiseenko, Valentina Shikina, Irina Titova, Nikita Savelov, Ilya Tsimafeyeu, Alexander Belonogov, Ahmed Abdelgafur, I. A. Demidova, Galina Statsenko, Evgeny N. Imyanitov, Elena Karabina, Oksana Barkovskaya, Aleksey Smirnov, Galina Makarnyaeva, Amir Khalimov, Aleksey Nebesnykh, Aleksey Mordovskiy, E. Filippova, Dmitry Isaichikov
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-7 (2019)
Journal of Global Oncology
Journal of Global Oncology
PURPOSE The overall survival (OS) results in patients with ALK-positive metastatic non–small-cell lung cancer (NSCLC) have rarely been reported. The aim of this prospective-retrospective cohort study was to obtain real-world data on the use of criz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5626ca9f42a5e4dc7972fd68557faf08
https://doi.org/10.1200/jgo.19.00024
https://doi.org/10.1200/jgo.19.00024
Autor:
M. I. Volkova, A. M. Abdelgafur, M. T. Aivazov, Z. V. Amoev, K. G. Babina, P. S. Borisov, A. A. Vorontsovа, I. V. Evstigneeva, O. I. Evsyukova, O. V. Zhelezin, A. S. Kalpinsky, E. V. Karabina, N. V. Kirdakova, G. P. Kolesnikov, E. S. Kuzmina, D. Kh. Latipova, R. V. Leonenkov, M. R. Maturov, A. V. Meskikh, S. V. Mishugin, E. G. Ovchinnikova, A. S. Olshanskaya, S. A. Protsenko, T. Yu. Semiglazova, R. V. Smirnov, E. A. Usynin, M. M. Fael, E. M. Cherniakova, I. E. Shumskaya
Publikováno v:
Onkourologiâ, Vol 15, Iss 3, Pp 56-69 (2019)
Objective: an assessment of efficacy and safety of lenvatinib in combination with everolimus in unselected patients with metastatic renal cell carcinoma (mRCC) progressed during or following ≥1 line of antiangiogenic targeted therapy.Material. Russ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13d301a22b53e5e52911c9452451cbb9
https://oncourology.abvpress.ru/oncur/article/view/984
https://oncourology.abvpress.ru/oncur/article/view/984
Autor:
Dmitry Kosov, Andrey Semenov, Sergey Gamayunov, Olga Novikova, Irina Sivunova, Ahmed Abdelgafur, Madina Ramazanova, Irina Guseva, Nadezhda Mikhailova, Ilya Tsimafeyeu, Marina Demchenkova, Gennady Bratslavsky, Roman Leonenkov, Zakhar Yurmazov, Pavel Borisov
Publikováno v:
Targeted oncology. 14(1)
Targeted therapy with axitinib resulted in a greater objective response rate and prolonged progression-free survival (PFS) compared to sorafenib in patients with previously treated metastatic renal cell carcinoma (mRCC) in the phase 3 AXIS study, whe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc3ab228f1a5fdbeab8b50206779ab6d
https://pubmed.ncbi.nlm.nih.gov/30607698
https://pubmed.ncbi.nlm.nih.gov/30607698
Autor:
Irina Chernyakova, Elena G. Ovchinnikova, Svetlana Protsenko, Tatiana Semiglazova, Evgeniya Kuzmina, Elena Karabina, Roman Smirnov, Roslercm, Ahmed Abdelgafur, Irina V. Evstigneeva, Evgeny Usynin, Natalia Kirdakova, Pavel Borisov, Dilorom Latipova, Magomed Aivazov, Alexei Kalpynsky, Anna Sergeevna Olshanskaya, Zurab Amoev, Olga Igorevna Samuseva, Ksenia Gennadievna Babina, Maria Volkova
Publikováno v:
Journal of Clinical Oncology. 38:644-644
644 Background: an assessment of efficacy and safety of lenvatinib in combination with everolimus in unselected patients with metastatic renal cell carcinoma (mRCC) progressed during or following ≥1 line of antiangiogenic targeted therapy. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2370b5133ab26d5935803e7937bd979
https://doi.org/10.1200/jco.2020.38.6_suppl.644
https://doi.org/10.1200/jco.2020.38.6_suppl.644